Literature DB >> 2943738

The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments.

M Handa, K Titani, L Z Holland, J R Roberts, Z M Ruggeri.   

Abstract

The glycoprotein Ib (GPIb), a two-chain integral platelet membrane protein, acts as a receptor for von Willebrand factor. In order to obtain information on the domain involved in this function, as well as on the structural organization of GPIb, the protein has been purified and submitted to limited proteolysis using three different enzymes. The resulting fragments were topographically oriented by means of partial NH2-terminal sequence analysis and immunological identification using monoclonal antibodies. One of these antibodies (LJ-Ib1) inhibited the von Willebrand factor-GPIb interaction completely, one (LJ-P3) partially, and one (LJ-Ib10) had no inhibitory effect. Three distinct fragments, the 38-kDa fragment produced by Serratia marcescens protease as well as the 45- and 35-kDa fragments produced by trypsin, had the same NH2 terminus as the intact GPIb alpha-chain (apparent molecular mass = 140 kDa). These fragments and the alpha-chain reacted with the inhibitory antibodies. On the other hand, three fragments produced by Staphylococcus aureus V8 protease, one of 92 kDa similar to the previously described "macroglycopeptide" and two others of 52 and 45 kDa, had NH2-terminal sequences different from that of the GPIb alpha-chain and reacted only with the noninhibitor monoclonal antibody LJIb10. Thus, the binding domain for von Willebrand factor resides near the NH2 terminus of the GPIb alpha-chain, whereas the carbohydrate-rich region is part of the innermost portion of GPIb and does not appear to be involved in the von Willebrand factor binding function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943738

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Platelet mimetic particles for targeting thrombi in flowing blood.

Authors:  Nishit Doshi; Jennifer N Orje; Blanca Molins; Jeffrey W Smith; Samir Mitragotri; Zaverio M Ruggeri
Journal:  Adv Mater       Date:  2012-05-29       Impact factor: 30.849

3.  Increased thrombin responsiveness in platelets from mice lacking glycoprotein V.

Authors:  V Ramakrishnan; P S Reeves; F DeGuzman; U Deshpande; K Ministri-Madrid; R B DuBridge; D R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

Authors:  J Ware; S Russell; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Authors:  H Douglas; K Michaelides; D A Gorog; E Durante-Mangoni; N Ahmed; G J Davies; E G D Tuddenham
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

6.  Vwf K1362A resulted in failure of protein synthesis in mice.

Authors:  Naomi Sanda; Nobuaki Suzuki; Atsuo Suzuki; Takeshi Kanematsu; Mayuko Kishimoto; Hidetoshi Hasuwa; Akira Takagi; Tetsuhito Kojima; Tadashi Matsushita; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2018-02-01       Impact factor: 2.490

7.  Stable expression in Chinese hamster ovary cells of a homogeneous recombinant active fragment of human platelet glycoprotein Ib alpha.

Authors:  B Schumpp-Vonach; G Kresbach; E J Schlaeger; B Steiner
Journal:  Cytotechnology       Date:  1995       Impact factor: 2.058

8.  Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.

Authors:  M Murata; S R Russell; Z M Ruggeri; J Ware
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects.

Authors:  R de Cristofaro; E de Candia; G Croce; R Morosetti; R Landolfi
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.